CTL is the only commercial entity that has extensive, first-hand expertise in all aspects of ELISPOT:

CTL's Founder and CEO, Prof. Dr. Paul V. Lehmann (CV), and the scientists working with him were the FIRST to:

More of Prof. Lehmann’s publications on ELISPOT are sorted here by theme, providing more information on the basics of ELISPOT and how it can be put to innovative use, possibly offering useful references for you.

If you have any questions about ELISPOT, contact us and our team of scientists, who have over 150 years of cumulative experience in ELISPOT. 

CTL Europe GmbH 
Hans-Boeckler-Str. 19-29 | 53225 Bonn, Germany
+49 228 85 44 78-0 | +49 228 85 44 78-22 Fax                     
Privacy Policy | Imprint | Sitemap
ctl-europe@immunospot.eu | www.immunospot.eu

© 2017 CTL Europe GmbH